The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower Extremity IschemiaReperfusion Injury Peptides After Peptide Sciences Renew Vitality About BPCA BPCA NICHD Eunice Kennedy Shriver National Institute of Child Health and Human Development